Abbott Laboratories
SIX:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
SIX:ABT
|
US |
|
Electrocomponents PLC
F:ECN
|
UK |
|
N
|
Nokia Oyj
DUS:NOA3
|
FI |
|
U
|
Ulta Beauty Inc
F:34U
|
US |
|
Safran SA
F:SEJU
|
FR |
|
Owl Rock Capital Corp
F:1D6
|
US |
|
Biogen Inc
NASDAQ:BIIB
|
US |
|
T
|
Transurban Group
F:TU9
|
AU |
|
Williams Companies Inc
NYSE:WMB
|
US |
|
HCL Technologies Ltd
NSE:HCLTECH
|
IN |
|
T
|
Telstra Corporation Ltd
OTC:TTRAF
|
AU |
|
A
|
Amazon.com Inc
XBER:AMZ
|
US |
|
H
|
Hasbro Inc
XMUN:HAS
|
US |
|
B
|
Boeing Co
XHAM:BCO
|
US |
|
Uniper SE
F:UN0
|
DE |
|
Singapore Airlines Ltd
OTC:SINGY
|
SG |
|
D
|
Diamondback Energy Inc
F:7DB
|
US |
|
C
|
Ctac NV
AEX:CTAC
|
NL |
|
T
|
TotalEnergies SE
XMUN:TOTB
|
FR |
|
Christian Dior SE
XETRA:DIO
|
FR |
|
Industria de Diseno Textil SA
F:IXD1
|
ES |
|
A
|
Accenture PLC
XMUN:CSA
|
IE |
|
N
|
NVIDIA Corp
DUS:NVD
|
US |
|
Clemondo Group AB (publ)
F:N17
|
SE |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABT is 103.4806 CHF with a low forecast of 87.9482 CHF and a high forecast of 120.7248 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
103.4806
CHF
According to Wall Street analysts, the average 1-year price target for ABT is 103.4806 CHF with a low forecast of 87.9482 CHF and a high forecast of 120.7248 CHF.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
18%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 18%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 17%.
